AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.
Create a link to this page
Copy and paste this link tag into your Web page or blog:
A natural human hormone looks like it's on track to be the first new treatment approved for systemic lupus erythematosus in 40 years.
Prasterone, which is the hormone dehydroepiandrosterone (DHEA), was safe and effective for improving systemic lupus erythematosus (SLE) symptoms and cutting the need for steroids in a phase III trial of 346 women with mild to moderate disease, Dr. Robert G. Lahita reported at the annual meeting of the American College of Rheumatology in Philadelphia.
The drug was also effective in reversing the bone density loss often seen in women with SLE who are treated with a corticosteroid.
If approved by the Food and Drug Administration for this indication, prasterone would be appropriate as a first-line treatment for patients with mild to moderate disease, experts said. It will probably not be useful for patients with more severe disease, such as those with severe nephritis. Furthermore, until results are analyzed ...